The Impact of Art Therapy on the Relationships Between Individuals Diagnosed With Alzheimer's Disease and Their Care Partners
NCT ID: NCT06725251
Last Updated: 2024-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2016-08-26
2022-08-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dementia Participants and Care Partners
Dyads including a participant diagnosed with dementia and the care partner
Art Therapy
Dyads will take part in a portrait-making project utilizing a collage approach. Each participant (i.e. dementia diagnosed individuals and care partners) will be instructed to create a portrait of him/herself. Participants will be provided with a sample portrait as well as bins of materials. \]The intervention will be administered for 1 ½ hours weekly, at the same day/time, for 4 consecutive weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Art Therapy
Dyads will take part in a portrait-making project utilizing a collage approach. Each participant (i.e. dementia diagnosed individuals and care partners) will be instructed to create a portrait of him/herself. Participants will be provided with a sample portrait as well as bins of materials. \]The intervention will be administered for 1 ½ hours weekly, at the same day/time, for 4 consecutive weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MMSE of 18-26, inclusive, administered within 6 month prior to screening or at screening
* Awareness of diagnosis and/or memory impairment, as determined by semi-structured interview with clinician (see Appendix B)
* Availability and willingness to participate in all 4 sessions of the intervention
* A care partner with whom the patient has regular weekly contact and who is available and willing to participate in all 4 sessions of the intervention
* Sufficient visual acuity to read 12-point font
* Sufficient manual dexterity to use scissors
* Ability to hear instructions in a classroom setting
* Ability to read English
* Age 18 years old or greater
* Adult 18 years of age or older
* Ability to consent
* Regular weekly contact with the subject diagnosed with Alzheimer's disease
* Availability and willingness to participate in all 4 sessions of the intervention
* Sufficient visual acuity to read 12-point font
* Sufficient manual dexterity to use scissors
* Ability to hear instructions in a classroom setting
* Ability to read English
Exclusion Criteria
* Current active psychiatric illness (e.g., major depression, schizophrenia, etc.)
* Current active seizure disorder.
* Malignancy or carcinoma currently requiring active treatment or progressing off of treatment.
* Recent history (within 1 year) of alcohol abuse or drug abuse.
* Active tobacco use that interferes with visits (e.g., if the patient would need to smoke during the therapy session).
* Use of medications (e.g., narcotics, sedatives, etc.) that lead to drowsiness during the therapy sessions
* Inability to comply with the instructions of the art therapist.
* Other unspecified reasons that, in the opinion of the Investigator make the subject unsuitable for enrollment.
* Prisoners
* Any uncontrolled medical or neurological/neurodegenerative condition sufficient to cause cognitive impairment
* Current active psychiatric illness (e.g., major depression, schizophrenia, etc.)
* Current active seizure disorder.
* Malignancy or carcinoma currently requiring active treatment or progressing off of treatment.
* Recent history (within 1 year) of alcohol abuse or drug abuse.
* Active tobacco use that interferes with visits (e.g., if the care partner would need to smoke during the therapy session).
Use of medications (e.g., narcotics, sedatives, etc.) that lead to drowsiness during the therapy sessions
* Inability to comply with the instructions of the art therapist.
* Other unspecified reasons that, in the opinion of the Investigator make the care partner unsuitable for enrollment.
* Prisoners
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
James R. and Helen D. Russell Center for Research and Innovation
UNKNOWN
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Darren Gitelman, MD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Advocate Memory Center
Park Ridge, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6409
Identifier Type: OTHER
Identifier Source: secondary_id
2016-102
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB00106942
Identifier Type: -
Identifier Source: org_study_id